Djibouti vs South Africa: Hepatitis B surface antigen (HBsAg) prevalence
Djibouti
1.0%
in 2024
South Africa
1.0%
in 2024
Djibouti rank
31st
South Africa rank
31st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Djibouti
- South Africa
How they compare
Djibouti currently reports 1.0% against 1.0% in South Africa, a difference of 0.0%.
Across all 10 years both countries report, South Africa has been ahead every year.
Djibouti ranks 31st and South Africa ranks 31st of 194 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.0% | 1.3% | 0.3% | South Africa |
| 2020s | 1.0% | 1.1% | 0.1% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Djibouti or South Africa?
- Djibouti, at 1.0% against 1.0% in South Africa as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Djibouti and South Africa?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and South Africa?
- 10 years are reported by both, from 2015 to 2024.
- How do Djibouti and South Africa rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Djibouti ranks 31st and South Africa ranks 31st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.